Francesca Fiorentino
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Francesca Fiorentino has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Candida Fonseca
Centro Hospitalar de Lisboa Ocidental, Heart Failure Unit, Department of Internal Medicine and Day Hospital Hospital São Francisco Xavier Lisbon Portugal
1 shared publication- Daniel Caldeira
Centro Cardiovascular da Universidade de Lisboa-CCUL (CCUL@RISE), CAML, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028, Lisboa, Portugal.
1 shared publication João Costa
Centro de Estudos de Medicina Baseada na Evidência (CEMBE), Faculdade de Medicina Universidade de Lisboa Lisbon Portugal
1 shared publicationMargarida Borges
Centro de Estudos de Medicina Baseada na Evidência (CEMBE), Faculdade de Medicina Universidade de Lisboa Lisbon Portugal
1 shared publicationMiguel Gouveia
Católica Lisbon School of Business and Economics Universidade Católica Portuguesa Lisbon Portugal
1 shared publicationPaula Broeiro-Gonçalves
Agrupamento de Centros de Saúde Lisboa Central Unidade de Cuidados de Saúde Personalizados dos Olivais Lisbon Portugal
1 shared publication
Latest Publications
- Open Access
- 8 January 2019
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 6 (2) , 254-261
The Current and Future Burden of Heart Failure in Portugal
Aims: Heart failure (HF) is a clinical syndrome with significant social and economic burden. We aimed to estimate the burden of HF in mainland Portugal over a 22-year time horizon, between 2014 and 2036. Methods and results: Heart failure burden was measured in disability-adjusted life years (DALYs), resulting from the sum of years of life lost (YLL) due to premature death and years lost due to disability (YLD). YLL were estimated based on the Portuguese mortality rates reported by the European Detailed Mortality Database. For YLD, disease duration and the overall incidence were estimated using an epidemiological model developed by the World Health Organization (DISMOD II). Disability weights were retrieved from published literature. The impact of ageing was estimated with a shift-share analysis using official demographic projections. In 2014, 4688 deaths were attributed to HF, corresponding to 4.7% of the total deaths in mainland Portugal. DALYs totalled 21 162, 53.9% due to premature death (YLL: 11 398) and 46.1% due to disability (YLD: 9765). Considering only population ageing over a 22-year horizon, the deaths and burden of HF are expected to increase by 73.0% and 27.9%, respectively, reaching 8112 deaths and 27 059 DALYs lost due to HF in 2036. DALY's growth is mainly driven by the increase of YLL, whose contribution to overall burden will increase to 62.0%. Conclusions: Heart failure is an emerging and growing health problem where significant health gains may be obtained. The projected significant increase of HF burden highlights the need to set HF as a priority for healthcare system.
- 8 January 2019
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 6 (2) , 254-261
Open AccessThe Current and Future Burden of Heart Failure in Portugal
Aims: Heart failure (HF) is a clinical syndrome with significant social and economic burden. We aimed to estimate the burden of HF in mainland Portugal over a 22-year time horizon, between 2014 and 2036. Methods and results: Heart failure burden was measured in disability-adjusted life years (DALYs), resulting from the sum of years of life lost (YLL) due to premature death and years lost due to disability (YLD). YLL were estimated based on the Portuguese mortality rates reported by the European Detailed Mortality Database. For YLD, disease duration and the overall incidence were estimated using an epidemiological model developed by the World Health Organization (DISMOD II). Disability weights were retrieved from published literature. The impact of ageing was estimated with a shift-share analysis using official demographic projections. In 2014, 4688 deaths were attributed to HF, corresponding to 4.7% of the total deaths in mainland Portugal. DALYs totalled 21 162, 53.9% due to premature death (YLL: 11 398) and 46.1% due to disability (YLD: 9765). Considering only population ageing over a 22-year horizon, the deaths and burden of HF are expected to increase by 73.0% and 27.9%, respectively, reaching 8112 deaths and 27 059 DALYs lost due to HF in 2036. DALY's growth is mainly driven by the increase of YLL, whose contribution to overall burden will increase to 62.0%. Conclusions: Heart failure is an emerging and growing health problem where significant health gains may be obtained. The projected significant increase of HF burden highlights the need to set HF as a priority for healthcare system.